Loading...
Header Logo
Keywords
Last Name
Institution

Sara Vesely

TitleDavid Ross Boyd Professor
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentBiostatistics & Epidemiology
Address801 NE 13th St
Oklahoma City OK 73104-5005
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Uhl L, Kiss JE, Malynn E, Terrell DR, Vesely SK, George JN. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 Jul 03. PMID: 28671324.
      View in: PubMed
    2. Reese JA, Peck JD, McIntosh JJ, Vesely SK, George JN. Platelet counts in women with normal pregnancies: A systematic review. Am J Hematol. 2017 Jun 19. PMID: 28631317.
      View in: PubMed
    3. Balch A, Wendelboe AM, Vesely SK, Bratzler DW. Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile. PLoS One. 2017; 12(6):e0179117. PMID: 28622340.
      View in: PubMed
    4. Green J, Oman RF, Vesely SK, Cheney MK, Carroll L. Prospective Associations Among Youth Religiosity and Religious Denomination and Youth Contraception Use. J Relig Health. 2017 Jun 14. PMID: 28616769.
      View in: PubMed
    5. Srour SA, Machiorlatti M, Pierson NT, Bhutta UZ, Cherry M, Selby GB, Thompson DM, Vesely SK, Kurkjian CD. Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2017 Jul; 17(7):450-456.e2. PMID: 28624543.
      View in: PubMed
    6. O'Brien SH, Koch T, Vesely SK, Schwarz EB. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care. 2017 Feb; 40(2):233-238. PMID: 27899496.
      View in: PubMed
    7. King AA, Vesely SK, Elwood J, Basso J, Carson K, Sung L. The American Society of Hematology Clinical Research Training Institute is associated with high retention in academic hematology. Blood. 2016 Dec 22; 128(25):2881-2885. PMID: 27784672.
      View in: PubMed
    8. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2016 Oct 27; 128(17):2175-2178. PMID: 27625362.
      View in: PubMed
    9. Samuelson BT, Vesely SK, Chai-Adisaksopha C, Scott BL, Crowther M, Garcia D. The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis: a meta-analysis. Blood Coagul Fibrinolysis. 2016 Sep; 27(6):648-52. PMID: 26569516.
      View in: PubMed
    10. Oman RF, Vesely SK, Green J, Fluhr J, Williams J. Short-Term Impact of a Teen Pregnancy-Prevention Intervention Implemented in Group Homes. J Adolesc Health. 2016 Nov; 59(5):584-591. PMID: 27544458.
      View in: PubMed
    11. Terrell DR, Reese J, Branesky D, Lu K, Watson SI, Thachil J, Vesely SK, George JN. Depression in adult patients with primary immune thrombocytopenia. Am J Hematol. 2016 Oct; 91(10):E462-3. PMID: 27434706.
      View in: PubMed
    12. Wahutu M, Vesely SK, Campbell J, Pate A, Salvatore AL, Janitz AE. Pancreatic Cancer: A Survival Analysis Study in Oklahoma. J Okla State Med Assoc. 2016 Jul-Aug; 109(7-8):391-398. PMID: 27885308.
      View in: PubMed
    13. Page EE, Jiang Y, Terrell DR, Vesely SK, George JN. Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes. Am J Hematol. 2016 Jun; 91(4):E278-9. PMID: 26822687.
      View in: PubMed
    14. Haegerich TM, Shults RA, Oman RF, Vesely SK. The Predictive Influence of Youth Assets on Drinking and Driving Behaviors in Adolescence and Young Adulthood. J Prim Prev. 2016 Jun; 37(3):231-45. PMID: 26779910.
      View in: PubMed
    15. Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2016 Jun 16; 127(24):3092-4. PMID: 27060171.
      View in: PubMed
    16. Liles NW, Page EE, Liles AL, Vesely SK, Raskob GE, George JN. Diversity and severity of adverse reactions to quinine: A systematic review. Am J Hematol. 2016 May; 91(5):461-6. PMID: 26822544.
      View in: PubMed
    17. Terrell DR, Stewart LM, Tolma EL, McClain R, Vesely SK, James JA. Barriers And Motivators for Smoking Cessation in Patients With Systemic Lupus Erythematosus (SLE). J Okla State Med Assoc. 2015 Nov; 108(11):492-9. PMID: 26817068.
      View in: PubMed
    18. Campbell JE, Janitz AE, Vesely SK, Lloyd D, Pate A. Patterns of Care for Localized Breast Cancer in Oklahoma, 2003-2006. Women Health. 2015; 55(8):975-95. PMID: 26133913; PMCID: PMC4746725.
    19. Han B, Page EE, Stewart LM, Deford CC, Scott JG, Schwartz LH, Perdue JJ, Terrell DR, Vesely SK, George JN. Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Aug; 90(8):709-14. PMID: 25975932; PMCID: PMC4509840.
    20. Walter AC, Gunderson CC, Vesely SK, Algan O, Sughrue M, Slaughter KN, Moore KN. Central nervous system metastasis in gynecologic cancer: symptom management, prognosis and palliative management strategies. Gynecol Oncol. 2015 Mar; 136(3):472-7. PMID: 25752572.
      View in: PubMed
    21. Reese JA, Bougie DW, Curtis BR, Terrell DR, Vesely SK, Aster RH, George JN. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol. 2015 May; 90(5):406-10. PMID: 25639727; PMCID: PMC4409501.
    22. Edgar CE, Terrell DR, Vesely SK, Wren JD, Dozmorov IM, Niewold TB, Brown M, Zhou F, Frank MB, Merrill JT, Kremer Hovinga JA, Lämmle B, James JA, George JN, Farris AD. Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura. PLoS One. 2015; 10(2):e0117614. PMID: 25671313; PMCID: PMC4324966.
    23. Cheney MK, Oman RF, Vesely SK, Aspy CB, Tolma EL, John R. Prospective association between negative life events and initiation of sexual intercourse: the influence of family structure and family income. Am J Public Health. 2015 Mar; 105(3):598-604. PMID: 25602885.
      View in: PubMed
    24. Lim W, Vesely SK, George JN. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31. PMID: 25573992; PMCID: PMC4351502.
    25. Oman RF, Vesely SK, Aspy CB, Tolma EL. Prospective Associations Among Assets and Successful Transition to Early Adulthood. Am J Public Health. 2015 Jan; 105(1):e51-e56. PMID: 25393188.
      View in: PubMed
    26. Cheney MK, Oman RF, Vesely SK. Prospective associations among youth assets in young adults and tobacco use. Am J Prev Med. 2015 Jan; 48(1 Suppl 1):S94-S101. PMID: 25528715.
      View in: PubMed
    27. McClain RS, Terrell DR, Vesely SK, George JN. Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion. 2014 Dec; 54(12):3257-9. PMID: 25496391.
      View in: PubMed
    28. Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8. PMID: 25414441; PMCID: PMC4304106.
    29. Cheney MK, Oman RF, Vesely SK, Aspy CB, Tolma EL. Prospective associations between negative life events and youth tobacco use. Am J Health Behav. 2014 Nov; 38(6):942-50. PMID: 25207519.
      View in: PubMed
    30. Haegerich TM, Oman RF, Vesely SK, Aspy CB, Tolma EL. The predictive influence of family and neighborhood assets on fighting and weapon carrying from mid- to late adolescence. Prev Sci. 2014 Aug; 15(4):473-84. PMID: 23677457; PMCID: PMC4710476.
    31. Aspy CB, Tolma EL, Oman RF, Vesely SK. The influence of assets and environmental factors on gender differences in adolescent drug use. J Adolesc. 2014 Aug; 37(6):827-37. PMID: 25086459; PMCID: PMC4121597.
    32. Little DJ, Reese JA, Vesely SK, George JN. Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency. Am J Kidney Dis. 2014 Aug; 64(2):317-8. PMID: 24797525.
      View in: PubMed
    33. Lu KH, George JN, Vesely SK, Terrell DR. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4. PMID: 23462246; PMCID: PMC3681891.
    34. Jiang Y, McIntosh JJ, Reese JA, Deford CC, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, Knudtson EJ, George JN. Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood. 2014 Mar 13; 123(11):1674-80. PMID: 24398329; PMCID: PMC3954049.
    35. Mushtaq N, Beebe LA, Vesely SK, Neas BR. A multiple motive/multi-dimensional approach to measure smokeless tobacco dependence. Addict Behav. 2014 Mar; 39(3):622-9. PMID: 24333034.
      View in: PubMed
    36. Nokes T, George JN, Vesely SK, Awab A. Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol. 2014 Feb; 92(2):156-63. PMID: 24164539.
      View in: PubMed
    37. Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK, George JN. Drug-induced thrombocytopenia in children. Pediatr Blood Cancer. 2013 Dec; 60(12):1975-81. PMID: 24038783.
      View in: PubMed
    38. Deford CC, Reese JA, Schwartz LH, Perdue JJ, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013 Sep 19; 122(12):2023-9; quiz 2142. PMID: 23838348; PMCID: PMC3778546.
    39. Gunderson CC, Farrell R, Dinh BC, Thomas ED, Vesely SK, Lauer JK, Kao L, Chopra S, McMeekin DS, Moore KN. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful? Gynecol Oncol. 2013 Sep; 130(3):411-5. PMID: 23791827.
      View in: PubMed
    40. Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82. PMID: 23729372.
      View in: PubMed
    41. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld E, Vesely SK, Adix L, Blanchette VS, Kühne T. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood. 2013 May 30; 121(22):4457-62. PMID: 23550040.
      View in: PubMed
    42. George JN, Vesely SK, Woolf SH. Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60. PMID: 23550214.
      View in: PubMed
    43. Oman RF, Vesely SK, Aspy CB, Tolma EL, Gavin L, Bensyl DM, Mueller T, Fluhr JD. A longitudinal study of youth assets, neighborhood conditions, and youth sexual behaviors. J Adolesc Health. 2013 Jun; 52(6):779-85. PMID: 23402985.
      View in: PubMed
    44. Griffin D, Al-Nouri ZL, Muthurajah D, Ross JR, Ballard RB, Terrell DR, Vesely SK, George JN, Marques MB. First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion. 2013 Jan; 53(1):235-7. PMID: 23294213; PMCID: PMC3541531.
    45. George JN, Vesely SK. A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry. Transfusion. 2012 Jul; 52(7):1593-4; author reply 1594-5. PMID: 22780896.
      View in: PubMed
    46. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol. 2012 Sep; 87(9):843-7. PMID: 22718340; PMCID: PMC3429706.
    47. Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012 Sep; 87(9):848-52. PMID: 22674643; PMCID: PMC3429719.
    48. Som S, Deford CC, Kaiser ML, Terrell DR, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524. PMID: 22501034; PMCID: PMC3402590.
    49. Monagle P, Chan AKC, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Göttl U, Vesely SK. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e737S-e801S. PMID: 22315277; PMCID: PMC3278066.
    50. George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med. 2012 Mar; 41(3 Pt 2):e177-88. PMID: 22244728.
      View in: PubMed
    51. Aspy CB, Vesely SK, Oman RF, Tolma E, Rodine S, Marshall L, Fluhr J. School-related assets and youth risk behaviors: alcohol consumption and sexual activity. J Sch Health. 2012 Jan; 82(1):3-10. PMID: 22142169.
      View in: PubMed
    52. Mushtaq N, Beebe LA, Vesely SK. Determinants of salivary cotinine concentrations among smokeless tobacco users. Nicotine Tob Res. 2012 Oct; 14(10):1229-34. PMID: 22180597.
      View in: PubMed
    53. Froehlich-Zahnd R, George JN, Vesely SK, Terrell DR, Aboulfatova K, Dong JF, Luken BM, Voorberg J, Budde U, Sulzer I, Lämmle B, Kremer Hovinga JA. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica. 2012 Feb; 97(2):297-303. PMID: 21993669; PMCID: PMC3269492.
    54. Tolma EL, Oman RF, Vesely SK, Aspy CB, Beebe L, Fluhr J. Parental youth assets and sexual activity: differences by race/ethnicity. Am J Health Behav. 2011 Sep; 35(5):513-24. PMID: 22040613.
      View in: PubMed
    55. Booth KK, Terrell DR, Vesely SK, George JN. Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol. 2011 Sep; 86(9):743-51. PMID: 21850657; PMCID: PMC3420338.
    56. Charania R, Smith J, Vesely SK, Dale GL, Holter J. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets. Transfusion. 2011 Dec; 51(12):2690-4. PMID: 21645004.
      View in: PubMed
    57. Bensyl DM, Vesely SK, Tolma EL, Oman RF, Aspy C. Associations between youth assets and sexual intercourse by household income. Am J Health Promot. 2011 May-Jun; 25(5):301-9. PMID: 21534832.
      View in: PubMed
    58. Terrell DR, Motto DG, Kremer Hovinga JA, Lämmle B, George JN, Vesely SK. Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion. 2011 Oct; 51(10):2237-43. PMID: 21470236; PMCID: PMC3151471.
    59. Newton JL, Reese JA, Watson SI, Vesely SK, Bolton-Maggs PH, George JN, Terrell DR. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol. 2011 May; 86(5):420-9. PMID: 21323737.
      View in: PubMed
    60. Cubbin C, Vesely SK, Braveman PA, Oman RF. Socioeconomic factors and health risk behaviors among adolescents. Am J Health Behav. 2011 Jan-Feb; 35(1):28-39. PMID: 20950156.
      View in: PubMed
    61. Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol. 2010 Nov; 85(11):844-7. PMID: 20799358; PMCID: PMC3420337.
    62. Oman RF, Vesely SK, Tolma EL, Aspy CB, Marshall LD. Reliability and validity of the youth asset survey: an update. Am J Health Promot. 2010 Sep-Oct; 25(1):e13-24. PMID: 20809821.
      View in: PubMed
    63. Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK. Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood. 2010 Sep 23; 116(12):2127-33. PMID: 20530792; PMCID: PMC2951857.
    64. Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar; 85(3):174-80. PMID: 20131303.
      View in: PubMed
    65. Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010 Feb 25; 115(8):1500-11; quiz 1662. PMID: 20032506.
      View in: PubMed
    66. Mueller T, Gavin L, Oman R, Vesely S, Aspy C, Tolma E, Rodine S. Youth assets and sexual risk behavior: differences between male and female adolescents. Health Educ Behav. 2010 Jun; 37(3):343-56. PMID: 19887626.
      View in: PubMed
    67. Guidry JA, Watson S, George JN, Vesely SK, Terrell DR. Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol. 2009 Nov; 83(5):497-8. PMID: 19614752.
      View in: PubMed
    68. Terrell DR, Beebe LA, George JN, Vesely SK, Mold JW. Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood. 2009 Apr 23; 113(17):4126-7. PMID: 19389893.
      View in: PubMed
    69. Benjamin M, Terrell DR, Vesely SK, Voskuhl GW, Dezube BJ, Kremer Hovinga JA, Lämmle B, George JN. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis. 2009 Apr 15; 48(8):1129-37. PMID: 19275493.
      View in: PubMed
    70. Guidry JA, George JN, Vesely SK, Kennison SM, Terrell DR. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol. 2009 Sep; 83(3):175-82. PMID: 19374704.
      View in: PubMed
    71. Moore KN, Frank SG, Alward EK, Landrum LM, Myers TK, Walker JL, Gold MA, McMeekin DS, Vesely SK, Mannel RS. Adjuvant chemotherapy for the "oldest old" ovarian cancer patients: can we anticipate toxicity-related treatment failure in a vulnerable population? Cancer. 2009 Apr 01; 115(7):1472-80. PMID: 19235786.
      View in: PubMed
    72. Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med. 2009 Mar 03; 150(5):293-300. PMID: 19258557.
      View in: PubMed
    73. Kennedy AS, Lewis QF, Scott JG, Kremer Hovinga JA, Lämmle B, Terrell DR, Vesely SK, George JN. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jun; 49(6):1092-101. PMID: 19222817.
      View in: PubMed
    74. Swisher KK, Terrell DR, Vesely SK, Kremer Hovinga JA, Lämmle B, George JN. Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion. 2009 May; 49(5):873-87. PMID: 19210323.
      View in: PubMed
    75. Nguyen L, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion. 2009 Feb; 49(2):392-4. PMID: 19389220.
      View in: PubMed
    76. Swisher KK, Li X, Vesely SK, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf. 2009; 32(1):85-6. PMID: 19132808.
      View in: PubMed
    77. Oman RF, Vesely SK, Aspy CB, Fluhr J, Marshall L, Calhoun G, Rodine S. Methodological considerations in a community-based longitudinal study. Am J Health Behav. 2009 Jan-Feb; 33(1):58-68. PMID: 18844521.
      View in: PubMed
    78. Lewis QF, Lanneau MS, Mathias SD, Terrell DR, Vesely SK, George JN. Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion. 2009 Jan; 49(1):118-24. PMID: 18954401.
      View in: PubMed
    79. Neunert CE, Buchanan GR, Imbach P, Bolton-Maggs PH, Bennett CM, Neufeld EJ, Vesely SK, Adix L, Blanchette VS, Kühne T. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008 Nov 15; 112(10):4003-8. PMID: 18698007; PMCID: PMC2581983.
    80. Karpac CA, Li X, Terrell DR, Kremer Hovinga JA, Lämmle B, Vesely SK, George JN. Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008 May; 141(5):696-707. PMID: 18422775.
      View in: PubMed
    81. Beebe LA, Vesely SK, Oman RF, Tolma E, Aspy CB, Rodine S. Protective assets for non-use of alcohol, tobacco and other drugs among urban American Indian youth in Oklahoma. Matern Child Health J. 2008 Jul; 12 Suppl 1:82-90. PMID: 18278544.
      View in: PubMed
    82. George JN, Kremer Hovinga JA, Terrell DR, Vesely SK, Lämmle B. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol. 2008 Apr; 80(4):277-86. PMID: 18221388.
      View in: PubMed
    83. George JN, Terrell DR, Swisher KK, Vesely SK. Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher. 2008; 23(4):129-37. PMID: 18618590.
      View in: PubMed
    84. Ambadwar P, Duvall D, Wolf NJ, Terrell DR, Vesely SK, George JN. Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher. 2008; 23(5):168-9. PMID: 18785649.
      View in: PubMed
    85. Behrens TK, Dinger MK, Vesely SK, Fields DA. Accuracy of step recording in free-living adults. Res Q Exerc Sport. 2007 Dec; 78(5):542-7. PMID: 18274225.
      View in: PubMed
    86. Hawkins BM, Abu-Fadel M, Vesely SK, George JN. Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion. 2008 Feb; 48(2):382-92. PMID: 18028268.
      View in: PubMed
    87. Nguyen L, Li X, Duvall D, Terrell DR, Vesely SK, George JN. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion. 2008 Feb; 48(2):349-57. PMID: 18028271.
      View in: PubMed
    88. Karpac CA, Lee A, Kunnel BS, Bamgbola OF, Vesely SK, George JN. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc. 2007 Nov; 100(11):429-33. PMID: 18183860.
      View in: PubMed
    89. Swisher KK, Doan JT, Vesely SK, Kwaan HC, Kim B, Lämmle B, Kremer Hovinga JA, George JN. Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica. 2007 Jul; 92(7):936-43. PMID: 17606444.
      View in: PubMed
    90. Johnson KK, Duvall D, Gilcher RO, Smith JW, Forsberg JE, Terrell DR, Vesely SK, George JN. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc. 2007 Jul; 100(7):273-8. PMID: 17896615.
      View in: PubMed
    91. George JN, Vesely SK, James JA. Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J. 2007 May; 100(5):512-4. PMID: 17534089.
      View in: PubMed
    92. Li X, Swisher KK, Vesely SK, George JN. Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf. 2007; 30(2):185-6. PMID: 17253882.
      View in: PubMed
    93. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007 Jan; 12(1):11-9. PMID: 17227897.
      View in: PubMed
    94. Oman RF, Vesely SK, Aspy CB, Tolma E, Rodine S, Marshall L, Fluhr J. Youth assets and sexual abstinence in Native American youth. J Health Care Poor Underserved. 2006 Nov; 17(4):775-88. PMID: 17242530.
      View in: PubMed
    95. Aspy CB, Vesely SK, Oman RF, Rodine S, Marshall L, Fluhr J, McLeroy K. Youth-parent communication and youth sexual behavior: implications for physicians. Fam Med. 2006 Jul-Aug; 38(7):500-4. PMID: 16823676.
      View in: PubMed
    96. Aspy CB, Vesely SK, Oman RF, Rodine S, Marshall L, McLeroy K. Parental communication and youth sexual behaviour. J Adolesc. 2007 Jun; 30(3):449-66. PMID: 16750265.
      View in: PubMed
    97. George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56. PMID: 16619232.
      View in: PubMed
    98. Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2006 Jan; 46(1):154-6. PMID: 16398746.
      View in: PubMed
    99. Oman RF, Vesely SK, Aspy CB. Youth assets, aggression, and delinquency within the context of family structure. Am J Health Behav. 2005 Nov-Dec; 29(6):557-68. PMID: 16336110.
      View in: PubMed
    100. Kegler MC, Oman RF, Vesely SK, McLeroy KR, Aspy CB, Rodine S, Marshall L. Relationships among youth assets and neighborhood and community resources. Health Educ Behav. 2005 Jun; 32(3):380-97. PMID: 15851545.
      View in: PubMed
    101. Wild RA, Vesely S, Beebe L, Whitsett T, Owen W. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005 Jul; 90(7):4112-4. PMID: 15827102.
      View in: PubMed
    102. Li X, Hunt L, Vesely SK. Drug-induced thrombocytopenia: an updated systematic review. Ann Intern Med. 2005 Mar 15; 142(6):474-5. PMID: 15767633.
      View in: PubMed
    103. Terrell DR, Johnson KK, Vesely SK, George JN. Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005 Feb 01; 105(3):1368-9. PMID: 15659620.
      View in: PubMed
    104. Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract. 2004 Sep-Oct; 17(5):309-18. PMID: 15355943.
      View in: PubMed
    105. Oman RF, Vesely SK, Aspy CB, McLeroy KR, Luby CD. The association between multiple youth assets and sexual behavior. Am J Health Promot. 2004 Sep-Oct; 19(1):12-8. PMID: 15460096.
      View in: PubMed
    106. Vesely SK, Li X, McMinn JR, Terrell DR, George JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion. 2004 Aug; 44(8):1149-58. PMID: 15265118.
      View in: PubMed
    107. Oman RF, Vesely S, Aspy CB, McLeroy KR, Rodine S, Marshall L. The potential protective effect of youth assets on adolescent alcohol and drug use. Am J Public Health. 2004 Aug; 94(8):1425-30. PMID: 15284054; PMCID: PMC1448466.
    108. Kojouri K, Vesely SK, Terrell DR, George JN. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood. 2004 Nov 01; 104(9):2623-34. PMID: 15217831.
      View in: PubMed
    109. Vesely SK, Wyatt VH, Oman RF, Aspy CB, Kegler MC, Rodine S, Marshall L, McLeroy KR. The potential protective effects of youth assets from adolescent sexual risk behaviors. J Adolesc Health. 2004 May; 34(5):356-65. PMID: 15093789.
      View in: PubMed
    110. George JN, Vesely SK. How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7. PMID: 15065609.
      View in: PubMed
    111. Rathbun SW, Whitsett TL, Vesely SK, Raskob GE. Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest. 2004 Mar; 125(3):851-5. PMID: 15006941; PMCID: PMC1215466.
    112. Raife T, Atkinson B, Montgomery R, Vesely S, Friedman K. Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion. 2004 Feb; 44(2):146-50. PMID: 14962303.
      View in: PubMed
    113. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion. 2004 Feb; 44(2):294-304. PMID: 14962323.
      View in: PubMed
    114. Vesely SK, Perdue JJ, Rizvi MA, Terrell DR, George JN. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2):112-20. PMID: 14734334.
      View in: PubMed
    115. George JN, Vesely SK, Terrell DR. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol. 2004 Jan; 41(1):60-7. PMID: 14727260.
      View in: PubMed
    116. George JN, Raskob GE, Vesely SK, Moore D, Lyons RM, Cobos E, Towell BL, Klug P, Guthrie TH. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol. 2003 Nov; 74(3):161-9. PMID: 14587042.
      View in: PubMed
    117. George JN, Vesely SK. Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med. 2003 Aug 28; 349(9):903-5. PMID: 12944577.
      View in: PubMed
    118. Vesely SK, George JN, Lämmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003 Jul 01; 102(1):60-8. PMID: 12637323.
      View in: PubMed
    119. McMinn JR, Thomas IA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion. 2003 Mar; 43(3):415-6. PMID: 12675731.
      View in: PubMed
    120. Hibbard AB, Medina PJ, Vesely SK. Reports of drug-induced thrombocytopenia. Ann Intern Med. 2003 Feb 04; 138(3):239. PMID: 12558372.
      View in: PubMed
    121. Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS, Kühne T. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol. 2003 Feb; 25(2):130-3. PMID: 12571464.
      View in: PubMed
    122. George JN, Vesely SK. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3. PMID: 12529099.
      View in: PubMed
    123. Lind SE, Caprini JA, Goldshteyn S, Dohnal JC, Vesely SK, Shevrin DH. Correlates of thrombin generation in patients with advanced prostate cancer. Thromb Haemost. 2003 Jan; 89(1):185-9. PMID: 12540969.
      View in: PubMed
    124. Howard MA, Duvall D, Terrell DR, Christopher AT, Thomas I, Holloway N, Vesely SK, George JN. A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher. 2003; 18(1):16-20. PMID: 12717788.
      View in: PubMed
    125. Oman RF, Vesely SK, Kegler M, McLeroy K, Aspy CB. A youth development approach to profiling sexual abstinence. Am J Health Behav. 2003; 27 Suppl 1:S80-93. PMID: 12751649.
      View in: PubMed
    126. Howard MA, Hibbard AB, Terrell DR, Medina PJ, Vesely SK, George JN. Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent). 2003 Jan; 16(1):21-6. PMID: 16278718; PMCID: PMC1200805.
    127. Oman RF, Vesely SK, McLeroy KR, Harris-Wyatt V, Aspy CB, Rodine S, Marshall L. Reliability and validity of the youth asset survey (YAS). J Adolesc Health. 2002 Sep; 31(3):247-55. PMID: 12225737.
      View in: PubMed
    128. Atkins LA, Oman RF, Vesely SK, Aspy CB, McLeroy K. Adolescent tobacco use: the protective effects of developmental assets. Am J Health Promot. 2002 Mar-Apr; 16(4):198-205. PMID: 11913325.
      View in: PubMed
    129. Beebe LA, Vesely SK, Baker K, Strader T. Tobacco cessation attitudes and behaviors among Oklahoma high school students. J Okla State Med Assoc. 2002 Mar; 95(3):176-9. PMID: 11921868.
      View in: PubMed
    130. Raife TJ, Lentz SR, Atkinson BS, Vesely SK, Hessner MJ. Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood. 2002 Jan 15; 99(2):437-42. PMID: 11781222.
      View in: PubMed
    131. Oman RF, McLeroy KR, Vesely S, Aspy CB, Smith DW, Penn DA. An adolescent age group approach to examining youth risk behaviors. Am J Health Promot. 2002 Jan-Feb; 16(3):167-76. PMID: 11802262.
      View in: PubMed
    Vesely's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _